Value Bridge — UT MD ANDERSON CANCER CENTER
Current $-39M → Target $69M (+$108.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-39.2M
Current EBITDA
$69.1M
Target EBITDA
+$108.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$24.5M
Payer Mix Optimization
$58.8M
Cost to Collect Reduction
$19.6M
Clean Claim Improvement
$14.7M
Volume & Rate Growth
$98.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-39M to $69M. The highest-impact lever is Volume & Rate Growth at $39.2M probability-weighted.
IC talking point: "We see $108M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $1191M in equity value creation."